About Us
Revolutionizing Alzheimer’s Intervention
Ortega NeuroRx is a biotechnology company transforming Alzheimer’s disease treatment by targeting a root cause long overlooked—age-related, self-reactive CD8 T cells. Acting upstream of amyloid and tau, Ortega’s therapies are designed to intercept these T cells by disrupting their presence, brain homing, and neurotoxic function—halting disease progression before cognitive decline becomes irreversible.
Our proprietary neuroimmune platform places Ortega NeuroRx at the forefront of Alzheimer’s innovation, advancing precision immunotherapy that reshapes how neurodegenerative diseases are detected, treated, and ultimately understood.
Sign up for Updates
Stay informed—sign up for email updates on Ortega NeuroRX's
breakthroughs and biotech innovations.
Our Science
Upstream Targeting. Lasting Change.
Ortega NeuroRx is pioneering immunotherapeutics that intercept Alzheimer’s disease at its earliest known immune trigger—self-reactive, age-related CD8 T cells. Our approach targets three key mechanisms: T cell presence, brain homing, and neurotoxic function—intervening upstream of amyloid and tau pathology.
Leveraging proprietary biomarkers and targeted biologics, Ortega blocks neuroinflammatory infiltration and modulates the immune activity that drives neurodegeneration. This precision, brain-directed platform enables earlier intervention, true disease modification, and a new era in Alzheimer’s care.